He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to destroy cancer cells.
Zelig Eshhar, Who Engineered Immune Cells to Fight Cancer, Dies at 84
He made a conceptual leap in immunotherapy by creating a hybrid T-cell, known as CAR-T, that was genetically modified to destroy cancer cells.